Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - TOTAL CURRENT ASSETS
Total Current Assets ADAP - Adaptimmune Therapeutics plc
208 M
LAST VALUE
-29.32%
2 YEAR CAGR
-2.13%
5 YEAR CAGR
62.64%
10 YEAR CAGR